FI105192B - Menetelmä ihmisen interleukiini-3:n mutanttien aikaansaamiseksi - Google Patents

Menetelmä ihmisen interleukiini-3:n mutanttien aikaansaamiseksi Download PDF

Info

Publication number
FI105192B
FI105192B FI903996A FI903996A FI105192B FI 105192 B FI105192 B FI 105192B FI 903996 A FI903996 A FI 903996A FI 903996 A FI903996 A FI 903996A FI 105192 B FI105192 B FI 105192B
Authority
FI
Finland
Prior art keywords
leu
asn
thr
ala
aac
Prior art date
Application number
FI903996A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI903996A0 (fi
Inventor
Leen Robert Willem Van
Lambertus Christiaan Dorssens
Original Assignee
Dsm Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26121243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI105192(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dsm Nv filed Critical Dsm Nv
Publication of FI903996A0 publication Critical patent/FI903996A0/fi
Application granted granted Critical
Publication of FI105192B publication Critical patent/FI105192B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI903996A 1989-08-14 1990-08-13 Menetelmä ihmisen interleukiini-3:n mutanttien aikaansaamiseksi FI105192B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP89202082 1989-08-14
EP89202082 1989-08-14
EP89202331 1989-09-14
EP89202331 1989-09-14

Publications (2)

Publication Number Publication Date
FI903996A0 FI903996A0 (fi) 1990-08-13
FI105192B true FI105192B (fi) 2000-06-30

Family

ID=26121243

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903996A FI105192B (fi) 1989-08-14 1990-08-13 Menetelmä ihmisen interleukiini-3:n mutanttien aikaansaamiseksi

Country Status (17)

Country Link
EP (2) EP0413383B1 (de)
JP (1) JP3192416B2 (de)
AT (1) ATE154638T1 (de)
AU (1) AU636641B2 (de)
CA (1) CA2023246C (de)
DD (1) DD301724A9 (de)
DE (1) DE69030937T2 (de)
DK (1) DK0413383T3 (de)
ES (1) ES2106017T3 (de)
FI (1) FI105192B (de)
GR (1) GR3024679T3 (de)
HU (1) HUT54411A (de)
IE (2) IE902921A1 (de)
IL (1) IL95350A0 (de)
NO (1) NO301481B1 (de)
NZ (1) NZ234869A (de)
PT (1) PT94992B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE179211T1 (de) * 1991-10-07 1999-05-15 Medvet Science Pty Ltd Menschliche il-3-varianten
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
JPH08503706A (ja) * 1992-11-24 1996-04-23 ジー．ディー．サール アンド カンパニー インターロイキン−３（ｉｌ−３）多重変異ポリペプチド
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6361977B1 (en) * 1992-11-24 2002-03-26 S. Christopher Bauer Methods of using multivariant IL-3 hematopoiesis fusion protein
US6413509B1 (en) 1992-11-24 2002-07-02 S. Christopher Bauer Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
NZ269766A (en) * 1993-07-28 1998-01-26 Medvet Science Pty Ltd Haemopoietic growth factor antagonists; relates to modified forms of such factors
US6465616B1 (en) 1994-04-08 2002-10-15 Bresagen Limited Interleukin-5 antagonist
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
US6270758B1 (en) 1998-10-08 2001-08-07 Duke University Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
JP4735670B2 (ja) * 2008-06-11 2011-07-27 富士ゼロックス株式会社 プリント基板および画像処理装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871029B (en) 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
AU617095B2 (en) 1986-12-16 1991-11-21 Dsm N.V. Molecular cloning and expression of human il-3
EP0790307A1 (de) 1986-12-16 1997-08-20 Gist-Brocades B.V. Molekulare Klonierung und Expression von menschlichem IL-3
EP0342206A4 (en) * 1987-01-20 1990-09-19 Immunex Corporation Human interleukin-3 proteins
US4743264A (en) * 1987-02-05 1988-05-10 Sherva Parker Carole J External prothesis with magnetic field
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".

Also Published As

Publication number Publication date
DE69030937D1 (de) 1997-07-24
PT94992B (pt) 1997-09-30
FI903996A0 (fi) 1990-08-13
JPH0420295A (ja) 1992-01-23
AU636641B2 (en) 1993-05-06
NO301481B1 (no) 1997-11-03
EP0810285A2 (de) 1997-12-03
NZ234869A (en) 1991-12-23
EP0810285A3 (de) 1998-07-08
CA2023246C (en) 2002-02-19
PT94992A (pt) 1991-04-18
NO903544D0 (no) 1990-08-13
DK0413383T3 (da) 1997-07-07
AU6096090A (en) 1991-02-14
JP3192416B2 (ja) 2001-07-30
EP0413383B1 (de) 1997-06-18
HUT54411A (en) 1991-02-28
GR3024679T3 (en) 1997-12-31
IE980055A1 (en) 2000-02-23
NO903544L (no) 1991-02-15
DE69030937T2 (de) 1997-10-09
ATE154638T1 (de) 1997-07-15
CA2023246A1 (en) 1991-02-15
EP0413383A1 (de) 1991-02-20
ES2106017T3 (es) 1997-11-01
DD301724A9 (de) 1993-08-12
IE902921A1 (en) 1991-02-27
IL95350A0 (en) 1991-06-30

Similar Documents

Publication Publication Date Title
AU632372B2 (en) Fusion proteins comprising gm-csf and il-3
JP3115561B2 (ja) 白血球を増加させるための医薬組成物の製造方法
US5108910A (en) DNA sequences encoding fusion proteins comprising GM-CSF and IL-3
US5516512A (en) N- and C-terminal truncation and deletion mutants of human interleukin-3
JP2644794B2 (ja) 新規な型のコロニー刺激因子―１
US5073627A (en) Fusion proteins comprising GM-CSF and IL-3
JPH10502801A (ja) 多重変異ｉｌ−３造血機能性融合タンパク質
AU606585B2 (en) Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
AU636641B2 (en) Mutants of human interleukin-3
JPH08503489A (ja) インターロイキン−３（ｉｌ−３）突然変異ポリペプチド
HU204890B (en) Process for producing human interleukin-3 and its muteins
JPH06133793A (ja) ミュレル管抑制物質様ポリペプチドおよびその製造方法
EP0482013A1 (de) Nicht glycosierte proteine, analoge des menschlichen interleukin-3.
WO1990001039A1 (en) Nonglycosylated human interleukin-3 compositions
WO1997012977A1 (en) Novel g-csf receptor agonists
EP0715633A1 (de) Antagonisten des hämopoietischen wachstumsfaktor
WO1992013548A1 (en) Method of inhibiting replication of hiv in macrophages
JP2660332B2 (ja) ヒトｍ−ｃｓｆの製造方法
HU209147B (en) Method for producing stimulating factor of human granulocytae colony
IE871727L (en) Novel family of primate il3-like hematopoietic growth¹factors.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: DSM N.V.

MM Patent lapsed

Owner name: DSM N.V.